期刊文献+
共找到14篇文章
< 1 >
每页显示 20 50 100
并购对中国上市公司研发绩效的影响研究——以医药行业为例 被引量:15
1
作者 杨军敏 曹志广 《商业经济与管理》 CSSCI 北大核心 2012年第4期26-31,共6页
通过并购来获取技术和知识是企业提高核心竞争力的重要手段,医药行业是知识密集型行业,专利数量是衡量一个医药企业是否具有竞争力的重要指标。文章以医药行业上市公司并购前后的专利增量作为研发绩效指标,以是否发生技术并购、并购企... 通过并购来获取技术和知识是企业提高核心竞争力的重要手段,医药行业是知识密集型行业,专利数量是衡量一个医药企业是否具有竞争力的重要指标。文章以医药行业上市公司并购前后的专利增量作为研发绩效指标,以是否发生技术并购、并购企业规模、并购次数、现有专利水平、研发强度为自变量,对2006-2009年的面板数据进行了回归分析。实证结果认为:技术并购对研发绩效有正面作用,而其它目的的并购对研发绩效有负面作用。 展开更多
关键词 技术并购 研发绩效 医药行业
下载PDF
中国通信设备与制药产业创新系统比较研究 被引量:9
2
作者 任声策 《科研管理》 CSSCI 北大核心 2013年第4期34-42,共9页
通信设备产业和医药产业都是中国重点支持发展的高新技术产业,但两个产业的差异也显而易见:通信设备产业具备较强的创新能力,无论是企业竞争力还是企业创新成果都从最初的毫无国际影响发展到处于国际领先水平。本文运用产业创新系统框架... 通信设备产业和医药产业都是中国重点支持发展的高新技术产业,但两个产业的差异也显而易见:通信设备产业具备较强的创新能力,无论是企业竞争力还是企业创新成果都从最初的毫无国际影响发展到处于国际领先水平。本文运用产业创新系统框架,对两个产业进行了比较分析。研究认为,产业知识基础(如技术机会)、行为人和网络(如市场需求、研发合作、政府支持等)和制度基础(如知识产权制度)三个方面能够一定程度的说明两个产业创新能力产生差异的原因。 展开更多
关键词 产业创新系统 通信设备业 制药业 比较
原文传递
医药行业需树立社会责任理念 被引量:2
3
作者 孙超 《中国卫生事业管理》 2007年第9期601-603,共3页
医药行业在全面建设小康社会的进程中,担负着重大使命与责任,树立社会责任理念,贯穿于医疗实践服务和医药企业生产经营过程,这对于构建和谐社会、实现社会公平、促进社会发展都有着重要的影响。同时,对于医药行业自身可持续发展也有着... 医药行业在全面建设小康社会的进程中,担负着重大使命与责任,树立社会责任理念,贯穿于医疗实践服务和医药企业生产经营过程,这对于构建和谐社会、实现社会公平、促进社会发展都有着重要的影响。同时,对于医药行业自身可持续发展也有着重要的促进作用。 展开更多
关键词 医药行业 企业社会责任 理念
下载PDF
Community Pharmacists’ Strategies in Greece: An Assessment of the Policy Environment and the Mapping of Key Players
4
作者 Athanassios Vozikis Lina Stavropoulou George P. Patrinos 《Health》 2015年第11期1560-1577,共18页
The aim of the study was to form and assess the pharmacists’ strategies in Greece, by analyzing the policy environment and identifying the role of the key players-stakeholders. For collecting and organizing important... The aim of the study was to form and assess the pharmacists’ strategies in Greece, by analyzing the policy environment and identifying the role of the key players-stakeholders. For collecting and organizing important information about the pharmacists’ policy, the PolicyMaker’s computerized version of political mapping was used, serving as a database for assessments of the policy’s content, the major players, the power and policy positions of key players, the interests of different players, and the networks and coalitions that connect the players. As the research findings show, the initially expected impact of the pharmacists’ policy proved to be very optimistic in most of the implemented strategies, as the majority of the strategies have worsened or minimized their success ratio throughout the time in study. Concluding, either the initially set strategies were at the wrong direction or the actions taken to implement them were inappropriate. Moreover, one can suggest that the shifting ability in both the position and the power of the most key players were over-estimated, while they under-estimated the impact of troika-constitutions meddling in the pharmaceutical policymaking and in the health sector cost-containment measures imposing. 展开更多
关键词 COMMUNITY PHARMACY STAKEHOLDER MAPPING pharmaceutical Policy Health sector Greece
下载PDF
Market Prospects of APIs in China in 2009
5
作者 Wu Huifang Beijing Orientbit Technology Co.,Ltd. 《China Chemical Reporter》 2009年第3期20-21,共6页
If making a forecast of the market for APIs(active pharmaceutical ingredients)in 2009,there are not enough favorable factors tosay"optimistic",and it would be too pes-simistic to say"downslide".Per... If making a forecast of the market for APIs(active pharmaceutical ingredients)in 2009,there are not enough favorable factors tosay"optimistic",and it would be too pes-simistic to say"downslide".Perhaps it isproper to say that the competition will be"fiercer".The aggravation of the global eco-nomic crisis will have anegative impact on almost every traditionalsector.The capital shortage and the consump-tion contraction will at least affect the marketconsumption growth of medicines.As medi-cines are irreplaceable commodities.the phar-maceutical sector can be said to be a harbor 展开更多
关键词 MEDICINES pharmaceutical sector SHORTAGE competiti
全文增补中
Pharmaceutical Exports Affected by Downturn in International Demand
6
《China Chemical Reporter》 2009年第3期22-22,共6页
Medicines are not directly involved in the fi-nancial crisis since they are basic consumablesand products with a demand that is relativelyinsensitive to consumer confidence,interestrates,etc.In the integrated global e... Medicines are not directly involved in the fi-nancial crisis since they are basic consumablesand products with a demand that is relativelyinsensitive to consumer confidence,interestrates,etc.In the integrated global economy oftoday,however,the pharmaceutical sector,including the production of active pharma-ceutical ingredients(APIs),can hardly be anexception.The situation for the export of APls inChina was excellent in the first eight monthsof2008.Nevertheless,we cannot reasonablysuppose that the impact of the financial crisison China’s export ofAPIs will be very small. 展开更多
关键词 pharmaceutical sector HARDLY consumer CONFIDENCE m
全文增补中
Where Should Pharmaceutical Intermediates Sector Go?
7
作者 Fang Wei,China National Chemical Information Center 《China Chemical Reporter》 2008年第22期20-20,共4页
Pharmaceutical intermediates have already become a major sector of the international chemical industry.The synthesis of pharma-ceuticals depends on high-quality pharmaceu-tical intermediates.No possibility of patent i... Pharmaceutical intermediates have already become a major sector of the international chemical industry.The synthesis of pharma-ceuticals depends on high-quality pharmaceu-tical intermediates.No possibility of patent infringement exists in the production of most pharmaceutical intermediates.The market and application prospects of pharmaceutical in-termediates are therefore most attractive. 展开更多
关键词 pharmaceutical sector ATTRACTIVE PATENT possibilit
全文增补中
Investment Focus in Pharmaceutical Sector
8
《China Chemical Reporter》 2007年第19期15-15,共2页
The pharmaceutical sector in China is shifting fromchaotic to standardized in order and hidden to evi-dent in rule. The production is getting more andmore concentrated. Leading companies still hold astrong position. B... The pharmaceutical sector in China is shifting fromchaotic to standardized in order and hidden to evi-dent in rule. The production is getting more andmore concentrated. Leading companies still hold astrong position. Biological medicines and famous-brand/modern Chinese medicines are sectors withprominent comparative advantage and will remainto be investment focuses in 2007 and 2008.There is only development trendbut no real performancein conventional 展开更多
关键词 MEDICINES pharmaceutical sector COMPANIES concentr
全文增补中
A Study on the Impact of PEST Analysis on the Pharmaceutical Sector: The Bangladesh Context
9
作者 Mohammad Nayeem Abdullah Robaka Shamsher 《Journal of Modern Accounting and Auditing》 2011年第12期1446-1456,共11页
PEST (Political, Economic, Social, and Technological) analysis of any industry sector investigates the important factors that are affecting the industry and influencing the companies operating in that sector. The pu... PEST (Political, Economic, Social, and Technological) analysis of any industry sector investigates the important factors that are affecting the industry and influencing the companies operating in that sector. The purpose of this study is to analyze the pharmaceutical sector of Bangladesh using the framework of PEST. This report brings to light the current state of the sector its progress and its problems. Through this study the researchers try to discuss the affect of various macro-economic factors of political, economic, social, and technological aspect on the industry and its related problems and prospects for the future. 展开更多
关键词 PEST analysis pharmaceutical sector industry and macro economic factors
下载PDF
Analysis of the Diethanolamine Market
10
作者 Hou Leshan, China National Chemical Information Center 《China Chemical Reporter》 2009年第16期28-29,共6页
Diethanolamine (DEA) is one of the productsin ethanolamine homologous series(including monoethanolamine (MEA), DEAand triethanolamine (TEA)). It is mainlyused in the production of herbicideglyphosate and also as corro... Diethanolamine (DEA) is one of the productsin ethanolamine homologous series(including monoethanolamine (MEA), DEAand triethanolamine (TEA)). It is mainlyused in the production of herbicideglyphosate and also as corrosion inhibitorfor the pharmaceutical sector, raw material for organic synthesis, raw material forsurfactants and absorbent for acidic gases.Present production statusThe ethanolamine production in China wasstarted in the 1960s. As raw material ethyl-ene oxide used at that time was mostly produced with the chlorohydrination process,it had a considerable amount of impurities. 展开更多
关键词 pharmaceutical sector GASES mostly Jiangsu HOMOLOG
全文增补中
Capacity Expansion of Sodium Metal in China
11
《China Chemical Reporter》 2009年第27期17-17,共6页
Sodium metal with strong reducibility is used to manufacture tetraethyl lead-an antiknock agent used in gasoline. After the use of leaded gasoline wasbanned, sodium metal is mainly used in dye industry for producing i... Sodium metal with strong reducibility is used to manufacture tetraethyl lead-an antiknock agent used in gasoline. After the use of leaded gasoline wasbanned, sodium metal is mainly used in dye industry for producing indigo,and pharmaceutical, pesticides, precious metals smelting industries and etc.The consumption of sodium metal in indigo dye sector occupies about 60%of China’s total consumption, while in pharmaceutical intermediates 展开更多
关键词 pharmaceutical sector GASOLINE SMELTING PESTICIDES
全文增补中
中国参与非洲公共卫生治理:基于医药投资合作的视角 被引量:13
12
作者 迟建新 《西亚非洲》 CSSCI 北大核心 2017年第1期87-112,共26页
中非公共卫生合作计划是中非"十大合作计划"之一,其中医药投资合作是中非双方落实公共卫生合作计划的重要着力点。当前非洲卫生体系薄弱,医药市场供需矛盾突出,但医药产业潜力巨大,中国企业拓展非洲医药市场机遇与挑战并存。... 中非公共卫生合作计划是中非"十大合作计划"之一,其中医药投资合作是中非双方落实公共卫生合作计划的重要着力点。当前非洲卫生体系薄弱,医药市场供需矛盾突出,但医药产业潜力巨大,中国企业拓展非洲医药市场机遇与挑战并存。目前,中国对非医药投资面临产业升级和市场竞争双重压力,投资规模普遍较小,医药企业"重生产、轻流通",国际市场开拓能力不足,医药"走出去"系统支持有待进一步强化。未来几年,中国应抓住对非医药产能合作机遇和投资窗口期,加强市场研究和前期规划,进一步提升投资合作层次,加大金融支持力度,探索医药领域"投援结合",增强企业投资能力,同时力促将中国医药标准与非洲医药标准实现互认互通,选择重点非洲国家,探讨打造"非洲药房"。 展开更多
关键词 公共卫生治理 中非合作 医药投资 “非洲药房”
原文传递
ESG表现与股票收益率——基于医药卫生行业的实证研究 被引量:5
13
作者 尹晓娜 李静萍 《统计学报》 2023年第1期73-82,共10页
随着全球经济向可持续发展转型,ESG投资受到了资本市场的广泛关注和认可。本文选取我国医药卫生行业上市公司2011—2020年的非平衡面板数据,基于固定效应模型,实证考察ESG表现对股票收益率的影响及作用机制。研究结果表明,医药卫生行业... 随着全球经济向可持续发展转型,ESG投资受到了资本市场的广泛关注和认可。本文选取我国医药卫生行业上市公司2011—2020年的非平衡面板数据,基于固定效应模型,实证考察ESG表现对股票收益率的影响及作用机制。研究结果表明,医药卫生行业上市公司的ESG表现对股票收益率有正向影响,但国有性质的上市公司ESG表现对股票收益率的影响不显著。进一步研究发现,财务绩效和企业竞争力都在ESG表现对股票收益率的作用机制中发挥部分中介效应。本文对新兴市场培育投资者价值投资理念以及完善ESG信息披露制度提供了启示。 展开更多
关键词 ESG表现 股票收益率 医药卫生行业 财务绩效 企业竞争力
下载PDF
我国医药制造业的区域分工现状分析
14
作者 桑晓冬 魏巍 +4 位作者 张小奕 李苏宁 濮润 敖翼 范玲 《中国生物工程杂志》 CAS CSCD 北大核心 2023年第9期113-119,共7页
目的:我国医药制造业的发展存在着区域差异,通过分析医药制造业在各省(区、市)的区域分工,了解和把握其分工规律和发展趋势,为构建我国生物医药产业高质量发展的可行路径提供决策依据和可行建议。方法:基于2010-2020年可获得的医药制造... 目的:我国医药制造业的发展存在着区域差异,通过分析医药制造业在各省(区、市)的区域分工,了解和把握其分工规律和发展趋势,为构建我国生物医药产业高质量发展的可行路径提供决策依据和可行建议。方法:基于2010-2020年可获得的医药制造业相关指标及数据,从区域经济学角度出发,运用集中度和区位熵等量化指标,分析我国医药制造业的区域分工和集聚情况。结果:2010-2020年京津冀地区、长三角地区、粤港澳大湾区和成渝地区的产业集中度整体表现为增长趋势,呈现出较高程度的产业聚集。东部地区各省份的区位熵整体表现为增长趋势,规模集中度不断提升,区域聚集效应表现较优。中部地区各省份的区位熵表现为相对稳定的发展趋势;西部地区和东北地区的区位熵整体表现为减少趋势。医药制造业未来有望成为江苏省和山东省的二级主导专业化部门,是北京、江西、湖北和四川4省(市)可选择的主导专业化部门。结论:医药制造业已经成为我国部分地区经济发展的支柱产业,其集聚化趋势逐步显现,区域分工呈现东、中、西部差异化。期望通过国家层面的战略规划、顶层设计、制度供给和服务管理,实现我国生物医药产业链分工和专业化发展,促进其高质量发展。 展开更多
关键词 医药制造业 区域分工 产业集中度 区位熵 主导化产业部门
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部